Ovary Lesions in Classical Hodgkin’s Lymphoma

AUTOIMMUNE THROMBOCYTOPENIA

SYu Smirnova1, TN Moiseeva1, LS Al-Radi1, AB Fedorov2, SA Makhinya1, NV Volkov1, GA Yatsyk1, IA Shupletsova1, AM Kovrigina1

1 National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167

2 MEDSI Clinical Hospital, block 2 с1А Pyatnitskoe sh., 6th km, Moscow Region, Russian Federation, 123464

For correspondence: Svetlana Yurevna Smirnova, MD, PhD, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167; Tel.: +7(926)879-65-94; e-mail: smirnova-s-ju@yandex.ru

For citation: Smirnova SYu, Moiseeva TN, Al-Radi LS, et al. Ovary Lesions in Classical Hodgkin’s Lymphoma. Clinical oncohematology. 2021;14(2):188–92. (In Russ).

DOI: 10.21320/2500-2139-2021-14-2-188-192

ABSTRACT

Hodgkin’s lymphoma is a tumor characterized by predominant lesions in lymph nodes. Primary extranodal lesions are exceedingly rare. In the now available world literature, there are only single observations of classical Hodgkin’s lymphoma with ovary involvements. The present paper reports the diagnosis and treatment of a patient with classical Hodgkin’s lymphoma with ovary involvements confirmed by histological and immunohistochemical analyses.

Keywords: Hodgkin’s lymphoma, ovaries.

Received: September 22, 2020

Accepted: February 16, 2021

Read in PDF

Статистика Plumx английский

REFERENCES

  1. Taheri MR, Dighe MK, Kolokythas O, et al. Multifaceted genitourinary lymphoma. Curr Probl Diagn Radiol. 2008;37(2):80–93. doi: 10.1067/j.cpradiol.2007.08.010.
  2. Lin PS, Gershenson DM, Bevers MW, et al. The current status of surgical staging of ovarian serous borderline tumors. Cancer. 1999;85(4):905–11. doi: 10.1002/(sici)1097-0142(19990215)85:4<905::aid-cncr19>3.0.co;2-8.
  3. Matasar MJ, Zelenetz AD. Overview of lymphoma diagnosis and management. Radiol Clin N Am. 2008;46(2):175–98. doi: 10.1016/j.rcl.2008.03.005.
  4. Vang R, Medeiros LJ, Fuller GN, et al. Non-Hodgkin’s lymphoma involving the gynecologic tract. A review of 88 cases. Adv Anat Pathol. 2001;8(4):200–17. doi: 10.1097/00125480-200107000-00002.
  5. Elharroudi T, Ismaili N, Errihani H, A Jalil. Primary lymphoma of the ovary. J Cancer Res Ther. 2008;4(4):195–6. doi: 10.4103/0973-1482.44291.
  6. Vang R, Medeiros LJ, Warnke RA, et al. Ovarian non-Hodgkin’s lymphoma: A clinicopathologic study of eight primary cases. Mod Pathol. 2001;14(11):1093–9. doi: 10.1038/modpathol.3880442.
  7. Мангасарова Я.К., Магомедова А.У., Ковригина А.М. и др. Экстрамедиастинальное поражение у больных первичной медиастинальной В-крупноклеточной лимфомой. Онкогематология. 2018;13(1):21–8.
    [Mangasarova YaK, Magomedova AU, Kovrigina AM, et al. Extramediastinal lesion in patients with primary mediastinal large B-cell Onkogematologiya. 2018;13(1):21–8. (In Russ)]
  8. Jackson H, Parker F. Hodgkin’s disease. II. Pathology. N Eng J Med. 1944;231:35–44.
  9. Heller EL, Palon W. Ovarian involvement in Hodgkin’s disease. Arch Path. 1946;41:282–9.
  10. Bare WW, McCloskey F. Primary Hodgkin’s disease of the ovary (report of a case). Obstet Gynec. 1961;17:477–80.
  11. Chorlton I, Norris HJ, King FM. Malignant reticuloendothelial disease involving the ovary as primary manifestation: a series of 19 lymphomas and 1 granulocytic sarcoma. Cancer. 1974;34(2):397–407. doi: 10.1002/1097-0142(197408)34:2<397::aid-cncr2820340225>3.0.co;2-0.
  12. Bittinger SE, Nazaretian SP, Gook DA, et al. Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril. 2011;95(2):803e3–803e6. doi: 10.1016/j.fertnstert.2010.07.1068.
  13. Khan MA, Dahill SW, Stewart KS. Primary Hodgkin’s disease of the ovary. Case report. Br J Obstet Gynaecol. 1986;93(12):1300–1. doi: 10.1111/j.1471-0528.1986.tb07870.x.
  14. Swerdlow SH., Campo E, Harris NL, et al. World Health Organization classification of tumors of haematopoietic lymphoid tissues. Revised 4th edition. Lyon: IARC Press; 2017.
  15. Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin’s disease and a subset of normal lymphoid cells. Nature. 1982;299(5878):65–7. doi: 10.1038/299065a0.
  16. Алгоритмы диагностики и протоколы лечения заболеваний системы крови. Под ред. В.Г. Савченко. М.: Практика, 2018. Том 2. С. 41–56.
    [Savchenko VG, ed. Algoritmy diagnostiki i protokoly lecheniya zabolevanii sistemy krovi. (Diagnostic algorithms and treatment protocols in hematological diseases.) Moscow: Praktika Publ.; 2018. Vol. 2. pр. 41–56. (In Russ)]
  17. Lassmann S, Gerlach UV, Technau-Ihling K, et al. Application of BIOMED-2 primers in fixed and decalcified bone marrow biopsies: analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin’s lymphomas. J Mol Diagn. 2005;7(5):582–91. doi: 10.1016/S1525-1578(10)60591-0.
  18. Сидорова Ю.В., Рыжикова Н.В., Смирнова С.Ю. и др. Определение В-клеточной клональности при лимфоме Ходжкина. Клиническая онкогематология. 2014;7(1):63–6.
    [Sidorova YuV, Ryzhikova NV, Smirnova SYu. Determination of B­cell clonality in Hodgkin’s lymphoma. Klinicheskaya onkogematologiya. 2014;7(1):63–6. (In Russ)]
  19. Ferrozzi F, Catanese C, Uccelli M, Bassi P. Ovarian lymphoma: Findings with ultrasonography, computerized tomography and magnetic resonance. Radio Med (Torino). 1998;95(5):493–7.
  20. Nelson GA, Dockerty MB, Pratt JH, ReMine WH. Malignant lymphoma involving the ovaries. Am J Obstet Gynecol. 1958;76(4):861–71. doi: 10.1016/0002-9378(58)90022-x.
  21. Skodras G, Fields V, Kragel PJ. Ovarian lymphoma and serous carcinoma of low malignant potential arising in the same ovary: A case report with review of literature of 14 primary ovarian lymphomas. Arch Pathol Lab Med. 1994;118(6):647–50.